...
首页> 外文期刊>Breast cancer research and treatment. >Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI
【24h】

Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI

机译:月经周期和更年期状态对弥散加权MRI浸润性导管癌表观弥散系数值和可检测性的影响

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study was to determine whether the apparent diffusion coefficient (ADC) and tumor detectability based on diffusion-weighted imaging (DWI) are affected by the menstrual cycle or menopausal status in breast cancer patients. Institutional review board approval was obtained, and the requirement for informed consent was waived. A total of 124 women with invasive ductal carcinoma not otherwise specified (IDC NOS) who underwent breast MRI with DWI were included in this study. Two radiologists retrospectively measured the ADCs of tumor and contralateral normal glandular tissue and scored the tumor detectability. The ADCs and detectability were compared to menstrual cycle and menopausal status, based on patient questionnaires. ADCs of tumors and contralateral tissue were significantly lower in postmenopausal women than in premenopausal women (P = 0.006 and P < 0.001, respectively). Tumor detectability did not differ significantly between the premenopausal and postmenopausal groups (P = 0.454). Normalized ADCs were not significantly lower in postmenopausal women compared to premenopausal women (P = 0.880). There was no statistically significant difference in the absolute, contralateral, and normalized ADCs (P = 0.091, 0.809, and 0.299, respectively), and the tumor detectability (P = 0.680) according to the menstrual cycle. Although ADCs of the IDC and normal glandular tissue in postmenopausal women were significantly lower than those in premenopausal women, the menstrual cycle did not affect tumor detectability and ADCs of IDC.
机译:这项研究的目的是确定表观扩散系数(ADC)和基于扩散加权成像(DWI)的肿瘤可检测性是否受乳腺癌患者的月经周期或绝经状态的影响。已获得机构审查委员会的批准,并且免除了知情同意的要求。本研究共纳入了124例未另作说明的浸润性导管癌(IDC NOS)妇女,她们均接受了DWI乳房MRI检查。两名放射科医师回顾性测量了肿瘤和对侧正常腺组织的ADC,并对肿瘤的可检测性进行了评分。根据患者调查表,将ADC和可检测性与月经周期和绝经状态进行了比较。绝经后妇女的肿瘤和对侧组织的ADC显着低于绝经前妇女(分别为P = 0.006和P <0.001)。绝经前和绝经后组之间的肿瘤可检测性没有显着差异(P = 0.454)。与绝经前女性相比,绝经后女性的标准化ADC并没有显着降低(P = 0.880)。根据月经周期,绝对,对侧和标准化ADCs(分别为P = 0.091、0.809和0.299)和肿瘤可检测性(P = 0.680)均无统计学差异。尽管绝经后妇女的IDC和正常腺组织的ADC明显低于绝经前妇女,但月经周期并未影响肿瘤的可检测性和IDC的ADC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号